查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1804312

切除技術的全球市場:各類型，各用途，各終端用戶，各地區 - 市場規模，產業動態，機會分析，預測(2025年～2034年)

Global Ablation Technology Market: By Type, Application, End Users, Region-Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2034
出版日期: | 出版商: Astute Analytica | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

受心血管疾病 (CVD)、實體腫瘤和慢性疼痛盛行率上升的推動，全球消融技術市場持續快速擴張。 2024 年市場規模估計為 68.2 億美元，預計到 2034 年將達到 167.4 億美元，預測期內複合年增長率為 9.82%。技術進步，尤其是脈衝場、低溫和微波消融系統，正在推動消融技術的應用不斷提升，尤其是在微創手術領域。美國、日本、印度和中國等國家的各個治療領域消融手術數量正在快速成長。例如，預計到2024年，光是美國就將進行超過48萬例心臟消融手術，而全球腫瘤消融手術將超過85萬例，其中肝癌消融手術將佔三分之一以上。

FDA批准的脈衝場消融 (PFA) 系統、人工智慧映射平台以及一次性探頭等創新技術正在改變臨床實踐。此外，門診手術中心因其成本效益和效率而越來越受到青睞，目前美國超過55%的消融手術在傳統醫院外進行。與此同時，由於醫療基礎設施的改善、政府舉措的出台以及電生理學和腫瘤學專家培訓的加強，亞太國家正在經歷快速擴張。

值得關注的市場發展

一系列進步正在推動消融技術的發展。脈衝場消融術可降低食道損傷風險並縮短手術時間，正迅速獲得廣泛認可，目前已占美國心臟消融手術的25%。美敦力的Affera平台和強生與Verily合作的纖維化映射工具等人工智慧引導系統正在提高手術準確性並降低重複消融率。目前，超過90%的肝臟腫瘤門診消融病例可當天出院，從而提高了醫療系統的效率。同時，在印度等國家，由於術後併發症顯著減少，攝護腺冷凍消融術的年增率為22%。

各公司正在合作開發針對門診環境優化的混合消融系統和模組化套件。例如，美敦力和通用電氣醫療集團已合作將即時MRI引導整合到消融平台中，從而改善腫瘤邊緣的可視化。不斷演變的報銷政策進一步支持了此類活動，例如美國擴大了醫療保險覆蓋範圍，以及巴西旨在降低設備成本和擴大服務欠缺地區醫療服務可及性的公私合作夥伴關係。

關鍵成長動力

1. 目標疾病盛行率上升：心房顫動 (AFib) 盛行率不斷上升，影響全球超過 2,600 萬人，局部癌症的盛行率顯著上升，這顯著增加了對消融治療的需求。

2. 微創治療的偏好：消融可以縮短恢復時間、減少創傷並降低住院費用，支持其廣泛應用。

3. 技術創新：便攜式、整合 AI 的系統和一次性探頭的出現改善了治療效果和病患安全性，尤其是在門診環境中。

4.政府支持和報銷政策：美國醫療保險和醫療補助計劃 (CMS) 報銷更新和亞太地區醫療補助補貼等政策正在創造良好的市場環境。

新興科技趨勢

  • 基於人工智慧的導航和地圖：超過 70% 的美國心臟實驗室採用這些技術，可優化消融精度並縮短手術時間。
  • 門診和心臟外科手術 (ASC) 優化：專為空間受限的門診環境設計的緊湊型模組化系統在該市場越來越受歡迎。
  • 跨專業整合：製造商優先考慮相容於心臟和腫瘤應用的設備，以最大限度地提高利用率和投資回報率。
  • 整合遠端監控：雅培 TriClip 等產品整合了即時數據採集功能，可實現後續護理並降低再入院率。

本報告探討並分析了全球消融技術市場，提供了每個細分市場的規模和預測、市場動態和趨勢以及公司概況。

目錄

第1章 調查架構

  • 調查目的
  • 產品概要
  • 市場區隔

第2章 調查手法

第3章 摘要整理:全球切除技術市場

第4章 全球切除技術市場概要

  • 產業價值鏈分析
    • 材料/零組件供應商
    • 廠商
    • 軟體·成像技術供應商
    • 銷售商·流通管道合作夥伴
    • 醫療提供者/終端用戶
  • 產業預測
    • 醫療器材進出口
    • 人工智慧整合醫療保健
    • 設備監管概述
    • 醫療保健中的數位設備交互
  • 大環境分析
  • 波特的五力分析
  • 市場動態和趨勢
    • 成長促進因素
    • 阻礙因素
    • 機會
    • 主要趨勢
  • 市場成長及預測
    • 市場收益的估計與預測(2020年～2034年)
  • 競爭儀表板
    • 市場集中率
    • 企業的市場佔有率分析(金額)(2024年)
    • 競爭製圖和基準
  • 實用的知識見解(分析師的建議)

第5章 全球切除技術市場分析:各類型

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 光/雷射
    • RF
    • 電力
    • 超音波
    • 微波
    • 冷凍治療
    • 水熱/水力機械性切除技術
    • 其他

第6章 全球切除技術市場分析:各用途

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 心血管疾病治療
    • 癌症治療
    • 眼科治療
    • 疼痛管理
    • 婦產科治療
    • 泌尿科治療
    • 整形外科治療
    • 美容整形手術
    • 其他

第7章 全球切除技術市場分析:各終端用戶

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 醫院
    • 手術中心
    • 切除中心
    • 門診病人手術中心(ASC)

第8章 全球切除技術市場分析:各地區

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第9章 北美的切除技術市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國

第10章 歐洲的切除技術市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國

第11章 亞太地區的切除技術市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國

第12章 中東·非洲的切除技術市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國

第13章 南美的切除技術市場分析

  • 重要的知識見解
  • 市場規模與預測(2020年～2034年)
    • 各類型
    • 各用途
    • 各終端用戶
    • 各國

第14章 企業簡介

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Abbott Laboratories
  • Terumo Medical Corporation
  • CONMED Corporation
  • AtriCure, Inc.
  • Stryker Corporation
  • Accuray
  • Smith & Nephew
  • AngioDynamics, Inc.
  • Varian Medical Systems
  • Olympus Corporation
  • 其他的著名的企業

第15章 附錄

簡介目錄
Product Code: AA04251290

The global ablation technology market is undergoing dynamic expansion, underpinned by the rising incidence of cardiovascular diseases (CVDs), solid tumors, and chronic pain conditions. Valued at US$ 6.82 billion in 2024, the market is expected to attain US$ 16.74 billion by 2034, growing at a CAGR of 9.82% over the forecast period. Technological evolution, especially in pulsed-field, cryo, and microwave ablation systems, is driving increased adoption, particularly in minimally invasive procedures. Countries like the U.S., Japan, India, and China are witnessing a significant surge in ablation procedures across therapeutic areas. For example, cardiac ablation volumes in the U.S. alone accounted for over 480,000 procedures in 2024, while tumor ablation exceeded 850,000 globally, with liver cancer ablation accounting for more than one-third of cases.

Innovations such as FDA-cleared pulsed-field ablation (PFA) systems, AI-enabled mapping platforms, and single-use probes are reshaping clinical practices. Additionally, outpatient and ambulatory surgical centers are increasingly preferred due to their cost-effectiveness and efficiency, with over 55% of ablation procedures in the U.S. now conducted outside traditional hospital settings. Simultaneously, Asia-Pacific countries are experiencing rapid expansion due to improving healthcare infrastructure, government-led initiatives, and increasing training for specialists in electrophysiology and oncology.

Noteworthy Market Developments

A series of advancements are reinforcing the momentum in the ablation technology landscape. Pulsed-field ablation, which reduces esophageal injury risks and procedural time, is rapidly gaining acceptance, already comprising 25% of U.S. cardiac ablation cases. AI-guided systems, such as Medtronic's Affera platform and Johnson & Johnson's fibrosis mapping tool (in partnership with Verily), are enhancing procedural accuracy and reducing repeat ablation rates. Outpatient ablation for liver tumors now facilitates same-day discharge in over 90% of cases, bolstering health system efficiency. Meanwhile, countries like India have witnessed a 22% year-on-year growth in prostate cryoablation, attributed to a substantial reduction in post-operative complications.

Companies are forming partnerships to develop hybrid ablation systems and modular kits optimized for ambulatory environments. Medtronic and GE Healthcare, for example, have collaborated to integrate real-time MRI guidance with ablation platforms, improving tumor margin visualization. These efforts are further supported by evolving reimbursement policies, such as Medicare's expanded coverage in the U.S., and public-private partnerships in Brazil aimed at reducing equipment costs and expanding access in underserved regions.

Core Growth Drivers

1. Rising Incidence of Target Conditions: Increasing prevalence of atrial fibrillation (AFib), which affects over 26 million people globally, and localized cancers is significantly contributing to the demand for ablation therapies.

2. Preference for Minimally Invasive Procedures: Ablation offers shorter recovery periods, less trauma, and reduced hospitalization costs, supporting widespread adoption.

3. Technological Innovations: The emergence of portable, AI-integrated systems and disposable probes enhances procedural outcomes and patient safety, especially in outpatient settings.

4. Government Support and Reimbursement Policies: Policies like the U.S. CMS's reimbursement updates and Asia-Pacific healthcare subsidies are creating favorable market environments.

Emerging Technology Trends

  • AI-Powered Navigation and Mapping: Used in more than 70% of cardiac labs in the U.S., these technologies optimize ablation precision and reduce procedure times.
  • Outpatient and ASC Optimization: The market is witnessing a trend toward compact, modular systems specifically designed for space-constrained ambulatory setups.
  • Cross-Specialty Integration: Devices that can cater to both cardiac and oncology applications are being prioritized by manufacturers to maximize utilization and ROI.
  • Remote Monitoring Integration: Products like Abbott's TriClip integrate real-time data capture, enabling follow-up care and reducing readmission rates.

Barriers to Optimization

  • High Equipment and Procedure Costs: Capital-intensive systems and high per-procedure costs are limiting penetration in low-income regions.
  • Regulatory Delays in Emerging Markets: Complex import regulations and delayed approvals are impeding product availability.
  • Workforce Gaps: Lack of trained electrophysiologists and interventional oncologists is a bottleneck in several developing countries.
  • Reimbursement Disparities: Coverage inconsistency across countries, especially in Europe and Latin America, restricts equitable access.

Market Segment Analysis

By Type:

Radiofrequency ablation leads the market, commanding 37% of total revenue in 2024. Its widespread use in oncology and pain management is attributed to high precision, cost-effectiveness, and robust clinical outcomes, such as an 89% 5-year survival rate in early-stage liver cancer.

Other types include:

  • Light/Laser
  • Electrical
  • Ultrasound
  • Microwave
  • Cryotherapy
  • Hydrothermal / Hydromechanical Ablation
  • Others

By Application:

Cardiovascular treatments dominate, contributing 43% of overall market share in 2024. The strong growth trajectory is fueled by guideline-recommended adoption of ablation as a first-line therapy for AFib, rising prevalence of arrhythmias, and favorable reimbursement policies.

Other key applications:

  • Cancer Treatment
  • Pain Management
  • Gynecological Treatment
  • Urological Treatment
  • Orthopedic Treatment
  • Cosmetic/Aesthetic Surgery
  • Ophthalmological Treatment
  • Others

By End Users:

Hospitals remain the primary end users, accounting for 66.35% of total utilization in 2024 due to their capacity to handle complex, multi-disciplinary cases, integrated diagnostic setups, and access to robotic systems and hybrid ORs.

Other end users include:

  • Surgical Centers
  • Ablation Centers
  • Ambulatory Surgical Centers (ASCs)

Geographic Insights

North America

Holding 48.3% of the global market share, North America is driven by high chronic disease burden, strong reimbursement frameworks, and rapid adoption of next-gen ablation platforms. Over 92% of regional revenue is concentrated in the U.S.

Europe

Europe represents 28% of the market, supported by aging populations and increasing outpatient procedure volumes. Germany and France are key contributors, though reimbursement inconsistencies across the continent pose challenges.

Asia Pacific

The fastest-growing region at a 13.2% CAGR, fueled by expanding CVD and cancer burdens, supportive government schemes, and emerging local manufacturers like Perfint Healthcare (India) and MicroPort (China).

Middle East & Africa

Adoption is rising, particularly in Gulf nations and South Africa, due to increasing private sector participation and initiatives to train specialists. However, cost barriers persist in low-income regions.

South America

Countries like Brazil and Argentina are increasing their investment in ablation infrastructure through PPPs and health system modernization programs, aiming to reduce dependency on imports and increase domestic access.

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN/South-East Asia
  • Rest of Asia Pacific
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Colombia
  • Rest of South America

Leading Market Participants

  • Medtronic Plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Abbott Laboratories
  • Terumo Medical Corporation
  • CONMED Corporation
  • AtriCure, Inc.
  • Stryker Corporation
  • Accuray
  • Smith & Nephew
  • AngioDynamics, Inc.
  • Varian Medical Systems
  • Olympus Corporation
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1 Research Objective
  • 1.2 Product Overview
  • 1.3 Market Segmentation

Chapter 2. Research Methodology

  • 2.1 Qualitative Research
    • 2.1.1 Primary & Secondary Sources
  • 2.2 Quantitative Research
    • 2.2.1 Primary & Secondary Sources
  • 2.3 Breakdown of Primary Research Respondents, By Region
  • 2.4 Assumption for the Study
  • 2.5 Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Ablation Technology Market

Chapter 4. Global Ablation Technology Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material/Component Provider
    • 4.1.2. Manufacturers
    • 4.1.3. Software & Imaging Technology Providers
    • 4.1.4. Distributors and Channel Partners
    • 4.1.5. Healthcare Providers/ End Users
  • 4.2. Industry Outlook
    • 4.2.1. EXIM of Medical Instruments
    • 4.2.2. Integration of AI in Healthcare
    • 4.2.3. Overview of Device Regulation
    • 4.2.4. Digital Device Interactions in Healthcare
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Opportunities
    • 4.5.4. Key Trends
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2034
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping & Benchmarking
  • 4.8. Actionable Insights (Analyst Recommendation's)

Chapter 5. Global Ablation Technology Market Analysis, By Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 5.2.1. Light/Laser
    • 5.2.2. Radiofrequency (RF)
    • 5.2.3. Electrical
    • 5.2.4. Ultrasound
    • 5.2.5. Microwave
    • 5.2.6. Cryotherapy
    • 5.2.7. Hydrothermal / Hydromechanical Ablation Technologies
    • 5.2.8. Others

Chapter 6. Global Ablation Technology Market Analysis, By Application

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 6.2.1. Cardiovascular Disease Treatment
    • 6.2.2. Cancer Treatment
    • 6.2.3. Ophthalmological Treatment
    • 6.2.4. Pain Management
    • 6.2.5. Gynecological Treatment
    • 6.2.6. Urological Treatment
    • 6.2.7. Orthopedic Treatment
    • 6.2.8. Cosmetic/Aesthetic Surgery
    • 6.2.9. Others

Chapter 7. Global Ablation Technology Market Analysis, By End Users

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 7.2.1. Hospitals
    • 7.2.2. Surgical Centers
    • 7.2.3. Ablation Centers
    • 7.2.4. Ambulatory Surgical Centers (ASCS)

Chapter 8. Global Ablation Technology Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 8.2.1. North America
      • 8.2.1.1. The U.S.
      • 8.2.1.2. Canada
      • 8.2.1.3. Mexico
    • 8.2.2. Europe
      • 8.2.2.1. The UK
      • 8.2.2.2. Germany
      • 8.2.2.3. France
      • 8.2.2.4. Italy
      • 8.2.2.5. Spain
      • 8.2.2.6. Poland
      • 8.2.2.7. Russia
      • 8.2.2.8. Rest of Europe
    • 8.2.3. Asia Pacific
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Australia
      • 8.2.3.6. ASEAN/ South-East Asia
      • 8.2.3.7. Rest of Asia Pacific
    • 8.2.4. Middle East & Africa
      • 8.2.4.1. UAE
      • 8.2.4.2. Saudi Arabia
      • 8.2.4.3. South Africa
      • 8.2.4.4. Rest of MEA
    • 8.2.5. South America
      • 8.2.5.1. Argentina
      • 8.2.5.2. Brazil
      • 8.2.5.3. Colombia
      • 8.2.5.4. Rest of South America

Chapter 9. North America Ablation Technology Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End Users
    • 9.2.4. By Country

Chapter 10. Europe Ablation Technology Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End Users
    • 10.2.4. By Country

Chapter 11. Asia Pacific Ablation Technology Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By End Users
    • 11.2.4. By Country

Chapter 12. Middle East and Africa Ablation Technology Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 12.2.1. By Type
    • 12.2.2. By Application
    • 12.2.3. By End Users
    • 12.2.4. By Country

Chapter 13. South America Ablation Technology Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 13.2.1. By Type
    • 13.2.2. By Application
    • 13.2.3. By End Users
    • 13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 14.1. Medtronic plc
  • 14.2. Boston Scientific Corporation
  • 14.3. Johnson & Johnson (Biosense Webster, Inc.)
  • 14.4. Abbott Laboratories
  • 14.5. Terumo Medical Corporation
  • 14.6. CONMED Corporation
  • 14.7. AtriCure, Inc.
  • 14.8. Stryker Corporation
  • 14.9. Accuray
  • 14.10. Smith & Nephew
  • 14.11. AngioDynamics, Inc.
  • 14.12. Varian Medical Systems
  • 14.13. Olympus Corporation
  • 14.14. Other Prominent Players

Chapter 15. Annexure

  • 15.1. List of Secondary Sources
  • 15.2. Key Country Markets- Macro Economic Outlook/Indicators